首页> 外文OA文献 >P1.04-73 Small Cell Transformation of Non-Small Cell Lung Cancer (NSCLC) on Immune Checkpoint Inhibitors: Case Report and Literature Review

【2h】

P1.04-73 Small Cell Transformation of Non-Small Cell Lung Cancer (NSCLC) on Immune Checkpoint Inhibitors: Case Report and Literature Review

机译：P1.04-73非小细胞肺癌（NSCLC）对免疫检查点抑制剂的小细胞转化：案例报告和文献综述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
K. Sehgal; A. Varkaris; P. Vanderlaan; D. Rangachari; D. Costa;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Hyper-progressive disease in a patient with advanced non-small cell lung cancer on immune checkpoint inhibitor therapy: A case report and literature review [J] . Zhang Dongxiao, Zhang Yan, Huang Yong, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2020,第1期

机译：患有先进的非小细胞肺癌免疫检查点抑制作用患者的超级渐进性疾病：案例报告和文献综述
2. Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review [J] . Wagner, Stollenwerk, H.K., Oncoimmunology. . 2020,第1期

机译：免疫检查点抑制剂在晚期非小细胞肺癌患者中的疗效和安全性（NSCLC）：系统文献综述
3. Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis [J] . Alfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, Frontiers in Oncology . 2019,第4期

机译：化学疗法与免疫检查点抑制剂组合用于先进的非小细胞肺癌患者的一线治疗：系统审查和基于文献的荟萃分析
4. Enumeration and ALK Investigation of Circulating Tumor Cells in Non-Small Cell Lung Cancer (NSCLC) Patients Using an Effective In Vivo Technology, the GILUPI CellCollector? [C] . Klaus Luecke, Lukasz Gasiorowski, Stefanie Herold, International Molecular Medicine Tri-Conference. . 2015

机译：使用有效的体内技术（Gilupi Cellcollector
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review [O] . Gernot Wagner, Hannah Karolina Stollenwerk, Irma Klerings, 2020

机译：免疫检查点抑制剂在晚期非小细胞肺癌（NSCLC）中的疗效和安全性：系统文献综述
7. PD2.03 Exploration of Factors Relating to Immune Response in Patients Treated with Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (NSCLC) [O] . A.F. Cardona, O. Arrieta, A. Ruiz-Patiño, 2019

机译：PD2.03对非小细胞肺癌免疫检查点抑制剂治疗的患者免疫应答因素探索（NSCLC）

P1.04-73 Small Cell Transformation of Non-Small Cell Lung Cancer (NSCLC) on Immune Checkpoint Inhibitors: Case Report and Literature Review

著录项

引文网络

相似文献

相关主题

期刊订阅